Details for New Drug Application (NDA): 016948
✉ Email this page to a colleague
NDA 016948 describes BENDOPA, which is a drug marketed by Valeant Pharm Intl and is included in one NDA. Additional details are available on the BENDOPA profile page.
The generic ingredient in BENDOPA is levodopa. There are eighteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the levodopa profile page.
The generic ingredient in BENDOPA is levodopa. There are eighteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the levodopa profile page.
Summary for 016948
| Tradename: | BENDOPA |
| Applicant: | Valeant Pharm Intl |
| Ingredient: | levodopa |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016948
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 500MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
